A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer
A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer
Enzastaurin given daily to participants with colorectal cancer who have Stage 4 disease and have not received prior chemotherapy for advanced colorectal cancer
Inclusion Criteria:
Exclusion Criteria:
Odense, 5000, Denmark
Vejle, 7100, Denmark